Immunomedics (IMMU) Misses Q4 EPS by 36c, Miss on Revenues
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Net (loss) attributable to Immunomedics, Inc. stockholders: -16.2M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net (loss) attributable to Immunomedics, Inc. stockholders: -16.2M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q4 EPS of ($0.48), $0.36 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $641 thousand versus the consensus estimate of $2.33 million.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
